Concepedia

Phillips Chimpeni

PC

5

Publications

869

Citations

5

H-Index

2002

Active since

Affiliations

Malawi-Liverpool-Wellcome Trust Clinical Research Programme(Current)

University of Liverpool

Liverpool School of Tropical Medicine

Michigan State University

University of Maryland, Baltimore

Phillips Chimpeni is an author at Malawi-Liverpool-Wellcome Trust Clinical Research Programme specializing in malaria, medicine, and pharmacology.

Top concepts

Publications per year

2002–2009

5

Publications

5

Molecular Markers for Failure of Sulfadoxine‐Pyrimethamine and Chlorproguanil‐Dapsone Treatment of <i>Plasmodium falciparum</i> Malaria

James G. Kublin, Fraction K. Dzinjalamala, Deborah Kamwendo et al. · The Journal of Infectious Diseases · 2002 · 523 citations · Full text

Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial

Ali Alloueche, W. S. Bailey, Sarah Barton et al. · The Lancet · 2004 · 107 citations

, , +4

Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study

Christopher V. Plowe, James G. Kublin, Fraction K. Dzinjalamala et al. · BMJ · 2004 · 94 citations · Full text

Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi

David Bell, Dan Wootton, Mavuto Mukaka et al. · Malaria Journal · 2009 · 78 citations · Full text

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial

J. Sulo, Phillips Chimpeni, Juanita Hatcher et al. · The Lancet · 2002 · 67 citations

, , +5

Rows per page

1–5 of 5